Rubin DT - Search Results

1

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.

Rubin DT, Dotan I, DuVall A, Bouhnik Y, Radford-Smith G, Higgins PDR, Mishkin DS, Arrisi P, Scalori A, Oh YS, Tole S, Chai A, Chamberlain-James K, Lacey S, McBride J, Panés J; HIBISCUS Study Group. Rubin DT, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):17-27. doi: 10.1016/S2468-1253(21)00338-1. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798036 Clinical Trial.

2

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus EV, Feagan BG, Colombel JF, Rubin DT, Wu EQ, Yu AP, Pollack PF, Chao J, Mulani P. Loftus EV, et al. Among authors: rubin dt. Am J Gastroenterol. 2008 Dec;103(12):3132-41. doi: 10.1111/j.1572-0241.2008.02175.x. Epub 2008 Oct 3. Am J Gastroenterol. 2008. PMID: 18853973 Clinical Trial.

3

Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.

Hoentjen F, Hanauer SB, Hart J, Rubin DT. Hoentjen F, et al. Among authors: rubin dt. J Clin Gastroenterol. 2013 Jan;47(1):52-7. doi: 10.1097/MCG.0b013e3182582c1d. J Clin Gastroenterol. 2013. PMID: 22858512 Free PMC article.

4

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Mahadevan U, et al. Among authors: rubin dt. Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92; quiz e24. doi: 10.1016/j.cgh.2012.11.011. Epub 2012 Nov 28. Clin Gastroenterol Hepatol. 2013. PMID: 23200982 Free PMC article.

5

What you see is not always what you get: raising the bar on clinical trial methodology in ulcerative colitis.

Rubin DT. Rubin DT. Gastroenterology. 2013 Jul;145(1):45-47. doi: 10.1053/j.gastro.2013.05.027. Epub 2013 May 29. Gastroenterology. 2013. PMID: 23726879 No abstract available.

6

Curbing our enthusiasm for fecal transplantation in ulcerative colitis.

Rubin DT. Rubin DT. Am J Gastroenterol. 2013 Oct;108(10):1631-3. doi: 10.1038/ajg.2013.279. Am J Gastroenterol. 2013. PMID: 24091506

7

U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.

Kinnucan J, Tomal J, Rubin DT. Kinnucan J, et al. Among authors: rubin dt. Inflamm Bowel Dis. 2015 Sep;21(9):2154-7. doi: 10.1097/MIB.0000000000000467. Inflamm Bowel Dis. 2015. PMID: 26197447

8

Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.

Rubin DT, Sandborn WJ, Bosworth B, Zakko S, Gordon GL, Sale ME, Rolleri RL, Golden PL, Barrett AC, Bortey E, Forbes WP. Rubin DT, et al. Dig Dis Sci. 2015 Nov;60(11):3408-17. doi: 10.1007/s10620-015-3868-5. Epub 2015 Sep 19. Dig Dis Sci. 2015. PMID: 26386854 Free PMC article.

9

Vedolizumab in the treatment of Crohn's disease.

Tarabar D, Hirsch A, Rubin DT. Tarabar D, et al. Among authors: rubin dt. Expert Rev Gastroenterol Hepatol. 2016;10(3):283-90. doi: 10.1586/17474124.2016.1135051. Epub 2016 Jan 25. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26810276 Review.

10

Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab.

Wichmann A, Krugliak Cleveland N, Rubin DT. Wichmann A, et al. Among authors: rubin dt. Am J Gastroenterol. 2016 Apr;111(4):577. doi: 10.1038/ajg.2016.21. Am J Gastroenterol. 2016. PMID: 27125715 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

474 results

Search Page